🔎 Trials Near Me

Akèy › Sipwa › Utah › Salt Lake City

Etid klinik pou Sipwa nan Salt Lake City, UT

13 etid pou Sipwa ap chèche patisipan nan sit nan ak bò kote Salt Lake City (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities

Ap rekriteFaz 3
  • AURORA-1 Clinical Site, Salt Lake City
Laj 18 ak plis · Tout sèks · Mizajou Sep 16, 2026 · NCT07743463

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes

Ap rekriteFaz 3
  • AURORA-2 Clinical Site, Salt Lake City
Laj 18 ak plis · Tout sèks · Mizajou Sep 16, 2026 · NCT07743450

A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes

Ap rekriteFaz 3
  • George E. Wahlen Department of Veterans Affairs Medical Center, Salt Lake City
Laj 18 ak plis · Tout sèks · Mizajou Sep 14, 2026 · NCT07351045

A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)

Ap rekriteFaz 3Volontè an sante akeyi
  • ACCOMPLISH-2 Research Site, Salt Lake City
Laj 18 a 79 · Tout sèks · Mizajou Sep 11, 2026 · NCT07654374

Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes

Ap rekriteFaz 3
  • Kailera Clinical Site, Salt Lake City
Laj 18 ak plis · Tout sèks · Mizajou Sep 3, 2026 · NCT07284901

Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)

Ap rekriteFaz 3
  • Pantheon Clinical Research, Bountiful · 9 mi lwen
Laj 18 a 99 · Tout sèks · Mizajou Sep 3, 2026 · NCT07684235

Efficacy and Safety of Ribupatide in Participants Living With Obesity or Overweight With Weight-Related Comorbidities Who Do Not Have Diabetes

Ap rekriteFaz 3
  • Kailera Clinical Site, Salt Lake City
Laj 18 ak plis · Tout sèks · Mizajou Sep 3, 2026 · NCT07284875

A Study of LY4174794 in Participants With Obesity or Overweight Who Are Otherwise Healthy

Ap rekriteFaz 1Volontè an sante akeyi
  • ICON Early Phase Services, LLC, Salt Lake City
Laj 18 a 65 · Tout sèks · Mizajou Sep 1, 2026 · NCT07654972

A Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes Mellitus

Ap rekriteFaz 3
  • Research Site, Salt Lake City
Laj 18 ak plis · Tout sèks · Mizajou Aug 25, 2026 · NCT07784725

Circadian Intervention to Improve Cardiometabolic Health

Ap rekriteVolontè an sante akeyi
  • College of Health Research Complex--University of Utah, Salt Lake City
Laj 18 a 45 · Tout sèks · Mizajou Aug 5, 2026 · NCT05943626

Effect of Sleep Extension on Ceramides in People With Overweight and Obesity

Ap rekriteVolontè an sante akeyi
  • College of Health Research Complex--University of Utah, Salt Lake City
Laj 18 a 45 · Tout sèks · Mizajou Aug 5, 2026 · NCT06180837

Testing a Tailored Approach to Long-Term Weight Loss Success

Ap rekriteVolontè an sante akeyi
  • University of Utah, Salt Lake City
Laj 18 a 65 · Tout sèks · Mizajou May 11, 2026 · NCT07577765

The Acute T-Rex (Timing of Resistance Exercise) Study

Ap rekrite
  • University of Utah HPER E Buildling, Salt Lake City
Laj 50 a 74 · Tout sèks · Mizajou Apr 3, 2025 · NCT06366399

Etid Sipwa nan lòt vil

Lòt etid nan Salt Lake City

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.